Composition for Improving Atopy Dermatitis Using an Extract of Rudbeckia laciniata

Disclosed in the present invention is a composition for alleviating atopic dermatitis using an extract of Rudbeckia laciniata that exhibits MDC and TARC expression inhibitory activity when treated with HaCaT cells, a human keratinocyte cell line treated with INF-γ and TNF-α. 본 발명은 INF-γ와 TNF-α로 처리된...

Full description

Saved in:
Bibliographic Details
Main Authors LEE JAE YEON, HONG SEONG SU, AHN EUN KYUNG, CHO YOUNG RAK, JUNG YEON WOO
Format Patent
LanguageEnglish
Korean
Published 13.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed in the present invention is a composition for alleviating atopic dermatitis using an extract of Rudbeckia laciniata that exhibits MDC and TARC expression inhibitory activity when treated with HaCaT cells, a human keratinocyte cell line treated with INF-γ and TNF-α. 본 발명은 INF-γ와 TNF-α로 처리된 인간각질형성세포주인 HaCaT 세포에 처리될 때 MDC 및 TARC 발현 억제 활성을 보이는 삼립국화 추출물을 이용한 아토피 피부염 개선용 조성물을 개시한다.
Bibliography:Application Number: KR20210173314